PAX3 expression in primary melanomas and nevi

Modern Pathology

Volumn 21, Issue 5, 2008, Pages 525-530

  Plummer, Rebecca S ^a   Shea, Christopher R ^a   Nelson, Maria ^a   Powell, Sara K ^a   Freeman, Diane M ^a   Dan, Colleen P ^a   Lang, Deborah ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Melanocyte; Melanoma; PAX3; Stem cell

Indexed keywords

TRANSCRIPTION FACTOR PAX3;

ADULT; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ELASTOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOMA; MELANOMA CELL; MOUSE; NEVUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; SUN EXPOSURE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; GENE EXPRESSION; HUMANS; MELANOMA; MICE; NEVUS, PIGMENTED; PAIRED BOX TRANSCRIPTION FACTORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN NEOPLASMS; SUNLIGHT; TUMOR MARKERS, BIOLOGICAL;

EID: 42549171011     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3801019     Document Type: Article

References (29)

1. Lang D, Lu MM, Huang L, et al. Pax3 functions at a nodal point in melanocyte stem cell differentiation. Nature 2005;433:884-887.
2. Muratovska A, Zhou C, He S, et al. Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene 2003;22:7989-7997.
3. Parker CJ, Shawcross SG, Li H, et al. Expression of PAX 3 alternatively spliced transcripts and identification of two new isoforms in human tumors of neural crest origin. Int J Cancer 2004;108:314-320.
4. Vachtenheim J, Novotna H. Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas. Cell Mol Biol 1999;45:1075-1082.
5. Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004;150:179-185.
6. Rivers JK. Is there more than one road to melanoma? Lancet 2004;363:728-730.
7. Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005;353:2135-2147.
8. Landi MT, Bauer J, Pfeiffer RM, et al. MC1R germline variants confer risk for BRAF-mutant melanoma. Science 2006;313:521-522.
9. Shea CR, Vollmer RT, Prieto VG. Correlating architectural disorder and cytologic atypia in Clark (dysplastic) melanocytic nevi. Hum Pathol 1999;30:500-505.
10. Le Douarin NM, Dupin E. Multipotentiality of the neural crest. Curr Opin Genet Dev 2003;13:529-536.
11. Lang D, Powell SK, Plummer RS, et al. PAX genes: roles in development, pathophysiology, and cancer. Biochem Pharmacol 2007;73:1-14.
12. Teillet MA, Le Douarin N. The migration of pigmentary cells studies by the method of heterospecific grafts of neural tube in bird embryo. C R Acad Sci Hebd Seances Acad Sci D 1970;270:3095-3098.
13. Hornyak TJ, Hayes DJ, Chiu LY, et al. Transcription factors in melanocyte development: distinct roles for Pax-3 and Mitf. Mech Dev 2001;101:47-59.
14. Watanabe A, Takeda K, Ploplis B, et al. Epistatic relationship between Waardenburg syndrome genes MITF and PAX3. Nat Genet 1998;18:283-286.
15. Santisteban P, Bernal J. Thyroid development and effect on the nervous system. Rev Endocr Metab Disord 2005;6:217-228.
16. Dressler GR, Wilkinson JE, Rothenpieler UW, et al. Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature 1993;362:65-67.
17. Murer L, Caridi G, Della Vella M, et al. Expression of nuclear transcription factor PAX2 in renal biopsies of juvenile nephronophthisis. Nephron 2002;91:588-593.
18. Winyard PJ, Risdon RA, Sams VR, et al. The PAX2 transcription factor is expressed in cystic and hyperproliferative dysplastic epithelia in human kidney malformations. J Clin Invest 1996;98:451-459.
19. Baumann Kubetzko FB, Di Paolo C, Maag C, et al. The PAX5 oncogene is expressed in N-type neuroblastoma cells and increases tumorigenicity of a S-type cell line. Carcinogenesis 2004;25:1839-1846.
20. Gnarra JR, Dressler GR. Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides. Cancer Res 1995;55:4092-4098.
21. Bernasconi M, Remppis A, Fredericks WJ, et al. Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins. Proc Natl Acad Sci USA 1996;93:13164-13169.
22. Tiffin N, Williams RD, Shipley J, et al. PAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cells. Br J Cancer 2003;89:327-332.
23. Toma JG, Akhavan M, Fernandes KJ, et al. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 2001;3:778-784.
24. Toma JG, McKenzie IA, Bagli D, et al. Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells 2005;23:727-737.
25. Dressler GR, Deutsch U, Chowdhury K, et al. Pax2, a new murine paired-box-containing gene and its expression in the developing excretory system. Development 1990;109:787-795.
26. Pani L, Horal M, Loeken MR. Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3-dependent development and tumorigenesis. Genes Dev 2002;16:676-680.
27. Margue CM, Bernasconi M, Barr FG, et al. Transcriptional modulation of the anti-apoptotic protein BCLXL by the paired box transcription factors PAX3 and PAX3/FKHR. Oncogene 2000;19:2921-2929.
28. Mishima Y. Melanocytic and nevocytic malignant melanomas. Cellular and subcellular differentiation. Cancer 1967;20:632-649.
29. Mishima Y, Matsunaka M. Pagetoid premalignant melanosis and melanoma: differentiation from Hutchinson's melanotic freckle. J Invest Dermatol 1975;65:434-440.